Filing Details
- Accession Number:
- 0000905148-24-001092
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-03 21:44:27
- Reporting Period:
- 2024-04-01
- Accepted Time:
- 2024-04-03 21:44:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1704292 | Zai Lab Ltd | ZLAB | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1731790 | Ying Du | C/O Zai Lab Limited 314 Main Street, 4Th Floor, Suite 100 Cambridge MA 02142 | Chairperson & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
American Depositary Shares | Acquisiton | 2024-04-01 | 10,800 | $16.72 | 1,110,359 | No | 4 | M | Direct | |
American Depositary Shares | Acquisiton | 2024-04-01 | 3,400 | $16.72 | 1,113,759 | No | 4 | M | Direct | |
American Depositary Shares | Disposition | 2024-04-02 | 4,400 | $16.15 | 1,109,359 | No | 4 | S | Direct | |
American Depositary Shares | Disposition | 2024-04-02 | 1,387 | $16.15 | 1,107,972 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
American Depositary Shares | Restricted Share Units | Disposition | 2024-04-01 | 10,800 | $0.00 | 10,800 | $0.00 |
American Depositary Shares | Restricted Share Units | Disposition | 2024-04-01 | 3,400 | $0.00 | 3,400 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
32,400 | No | 4 | M | Direct | ||
6,800 | No | 4 | M | Direct |
Footnotes
- Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
- ADSs acquired on vesting of Restricted Share Units.
- These ADSs were sold automatically to cover taxes upon vesting of Restricted Share Units.
- Each Restricted Share Unit ("RSU") represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer.
- The RSUs vest in equal annual installments over five years beginning on 04/01/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting.
- The RSUs vest in equal annual installments over five years beginning on 04/01/2022, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting.